We are live on ! Find out more
Adage Capital Partners

Adage Capital Partners Portfolio holdings

AUM $64.8B
1-Year Est. Return 42.7%
This Fund
S&P 500
This Quarter Est. Return
-1.78%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+879.75%
AUM
$54B
AUM Growth
-$3.2B
Cap. Flow
-$865M
Cap. Flow %
-1.6%
Top 10 Hldgs %
28.71%
Holding
986
New
116
Increased
314
Reduced
359
Closed
149

Top Buys

Rank Stock Value
1
HUBB icon
Hubbell
HUBB
+$244M
2
NSC icon
Norfolk Southern
NSC
+$149M
3
INSM icon
Insmed
INSM
+$138M
4
VRTX icon
Vertex Pharmaceuticals
VRTX
+$131M
5
DHR icon
Danaher
DHR
+$119M

Top Sells

Rank Stock Value
1
RPRX icon
Royalty Pharma
RPRX
+$340M
2
BMY icon
Bristol-Myers Squibb
BMY
+$339M
3
UNP icon
Union Pacific
UNP
+$191M
4
MCD icon
McDonald's
MCD
+$190M
5
HES
Hess
HES
+$168M

Sector Composition

Rank Sector Weight
1 Technology 26.3%
2 Healthcare 14.99%
3 Financials 12.56%
4 Consumer Discretionary 9.54%
5 Industrials 8.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RLAY icon
926
Relay Therapeutics
RLAY
$4.3B
-1,400,000
Closed -$5.77M
ROP icon
927
Roper Technologies
ROP
$39.3B
-116,813
Closed -$60.7M
RZLT icon
928
Rezolute
RZLT
$453M
-2,525,883
Closed -$12.4M
SIGI icon
929
Selective Insurance
SIGI
$5.77B
-10,000
Closed -$935K
SILJ icon
930
Amplify Junior Silver Miners ETF
SILJ
$3.63B
-75,000
Closed -$745K
SLG icon
931
SL Green Realty
SLG
$3.86B
-35,000
Closed -$2.38M
SLRN
932
DELISTED
ACELYRIN
SLRN
-450,000
Closed -$1.41M
SNOW icon
933
Snowflake
SNOW
$110B
-107,500
Closed -$16.6M
SRPT icon
934
Sarepta Therapeutics
SRPT
$1.77B
-175,000
Closed -$21.3M
ST icon
935
Sensata Technologies
ST
$6.74B
-582,538
Closed -$16M
STX icon
936
Seagate
STX
$193B
-94,101
Closed -$8.12M
SVRA icon
937
Savara
SVRA
$1.19B
-2,115,771
Closed -$6.5M
SYY icon
938
Sysco
SYY
$40.4B
-133,224
Closed -$10.2M
TARA icon
939
Protara Therapeutics
TARA
$230M
-2,250,000
Closed -$11.9M
TFX icon
940
Teleflex
TFX
$6.15B
-3,405
Closed -$606K
TKR icon
941
Timken Company
TKR
$8.92B
-240,664
Closed -$17.2M
TPG icon
942
TPG
TPG
$7.78B
-65,000
Closed -$4.08M
TRU icon
943
TransUnion
TRU
$15.2B
-90,000
Closed -$8.34M
TSHA icon
944
Taysha Gene Therapies
TSHA
$1.82B
-5,000,000
Closed -$8.65M
TWLO icon
945
Twilio
TWLO
$29.3B
-35,000
Closed -$3.78M
TXRH icon
946
Texas Roadhouse
TXRH
$13.7B
-66,407
Closed -$12M
TYRA icon
947
Tyra Biosciences
TYRA
$1.61B
-200,000
Closed -$2.78M
UGI icon
948
UGI
UGI
$7.35B
-425,000
Closed -$12M
VALE icon
949
Vale
VALE
$62.6B
-450,000
Closed -$3.99M
VERA icon
950
Vera Therapeutics
VERA
$2.3B
-480,000
Closed -$20.3M

Similar funds

Adage Capital Partners's Q1 2025 Portfolio in Review

As of Q1 2025, Adage Capital Partners held 986 positions worth $54B, down 5.6% from $57.2B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Adage Capital Partners's Q1 2025 filing shows 116 new, 314 increased, 359 reduced and 149 closed positions. Its largest new stake was Diamondback Energy: 485,503 shares worth $77.6M. The largest sale was Royalty Pharma, an estimated $340M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 29% a quarter earlier, followed by Healthcare and Financials.

  • Adage Capital Partners's largest Q1 2025 buy was Diamondback Energy: 485,503 shares worth $77.6M.
  • Adage Capital Partners added most to Hubbell in Q1 2025, an estimated $244M increase.
  • Adage Capital Partners's biggest Q1 2025 reduction was Royalty Pharma, cutting an estimated $340M.
  • Adage Capital Partners fully exited Geron in Q1 2025, selling an estimated $77.2M.
  • Adage Capital Partners's ten largest holdings make up 29% of its $54B portfolio in Q1 2025.
  • Adage Capital Partners opened 116 new positions and closed 149 in Q1 2025.
  • Adage Capital Partners's portfolio value fell 5.6% quarter-over-quarter to $54B.

Based on Adage Capital Partners's 13F filing for Q1 2025, filed 15 May 2025.